A Genetic Variant in the Promoter Region of miR-106b-25 Cluster Predict Clinical Outcome of HBV-Related Hepatocellular Carcinoma in Chinese

• Fuzhen Qi ,

  Contributed equally to this work with: Fuzhen Qi, Mingde Huang

  Affiliation Department of Hepatopancreatobiliary Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, China

  ⨯
• Mingde Huang ,

  Contributed equally to this work with: Fuzhen Qi, Mingde Huang

  Affiliation Department of Medical Oncology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, China

  ⨯
• Yun Pan,

  Affiliation Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China

  ⨯
• Yao Liu,

  Affiliation Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China

  ⨯
• Jibin Liu,

  Affiliation Department of Hepatobiliary Surgery, Nantong Tumor Hospital, Nantong, Jiangsu, China

  ⨯
• Juan Wen,

  Affiliation Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China

  ⨯
• Kaipeng Xie,

  Affiliation Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China

  ⨯
• Hongbing Shen,

  Affiliations Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China

  ⨯
• Hongxia Ma ,

  * E-mail: hongxiama@njmu.edu.cn (HM); miaoyi@njmu.edu.cn (YM); zhibin_hu@njmu.edu.cn (ZH)

  Affiliations Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China

  ⨯
• Yi Miao ,

  * E-mail: hongxiama@njmu.edu.cn (HM); miaoyi@njmu.edu.cn (YM); zhibin_hu@njmu.edu.cn (ZH)

  Affiliation Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

  ⨯
• Zhibin Hu

  * E-mail: hongxiama@njmu.edu.cn (HM); miaoyi@njmu.edu.cn (YM); zhibin_hu@njmu.edu.cn (ZH)

  Affiliations Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China

  ⨯